Your Location:
Home >
Browse articles >
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Tengshen Granules for Treatment of Grade 1 Hypertension
Updated:2026-10-08
    • A Randomized, Double-blind, Placebo-controlled Clinical Trial of Tengshen Granules for Treatment of Grade 1 Hypertension

    • “The clinical efficacy of Tengshen Granules in treating grade 1 hypertension with liver heat and excessive yang, and mild kidney yin deficiency is outstanding. The research team has verified the antihypertensive effect of traditional Chinese medicine compound, opening up a new direction for the integrated treatment of hypertension with traditional Chinese and Western medicine.”
    • PENG Yuru , HUAN Jiaming , XIN Laiyun , WANG Zhenyuan , WANG Cong , LI Yunlun
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 21, Pages: 168-176(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251724     

      CLC:
    • Revised:2025-07-10 ,

      Accepted:22 July 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

318

Views

82

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Traditional Chinese Medicine Intervention in Parkinson's Disease Based on Keap1/Nrf2/ARE Signaling Pathway: A Review
Regulatory Pathways of Cell Apoptosis in Diabetic Kidney Disease and Intervention by Traditional Chinese Medicine: A Review

Related Author

No data

Related Institution

No data